Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Allolio

Showing results (131-140 of 145) with videos related to

Pageof 15
Sort By:
The Journal of Clinical Endocrinology and Metabolism|July 25, 2014
Novel somatic mutations in the catalytic subunit of the protein kinase A as a cause of adrenal Cushing's syndrome: a European multicentric studyGuido Di Dalmazi, Caroline Kisker, Davide Calebiro, et al.
European Urology|November 26, 2013
Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancerAlfredo Berruti, Martin Fassnacht, Harm Haak, et al.
Hypertension (Dallas, Tex. : 1979)|December 29, 2011
KCNJ5 mutations in European families with nonglucocorticoid remediable familial hyperaldosteronismPaolo Mulatero, Philipp Tauber, Maria-Christina Zennaro, et al.
The Journal of Clinical Endocrinology and Metabolism|September 16, 2011
Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumorsWiebke Arlt, Michael Biehl, Angela E Taylor, et al.
Hypertension (Dallas, Tex. : 1979)|May 29, 2014
Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenomaFabio Luiz Fernandes-Rosa, Tracy Ann Williams, Anna Riester, et al.
The New England Journal of Medicine|June 8, 2007
Adjuvant mitotane treatment for adrenocortical carcinomaMassimo Terzolo, Alberto Angeli, Martin Fassnacht, et al.
The Journal of Clinical Endocrinology and Metabolism|November 20, 2012
Mitotane therapy in adrenocortical cancer induces CYP3A4 and inhibits 5α-reductase, explaining the need for personalized glucocorticoid and androgen replacementVasileios Chortis, Angela E Taylor, Petra Schneider, et al.
The Journal of Clinical Endocrinology and Metabolism|January 7, 2015
Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resectionFelix Beuschlein, Jens Weigel, Wolfgang Saeger, et al.
Nature Genetics|February 19, 2013
Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertensionFelix Beuschlein, Sheerazed Boulkroun, Andrea Osswald, et al.
The New England Journal of Medicine|February 28, 2014
Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndromeFelix Beuschlein, Martin Fassnacht, Guillaume Assié, et al.
Pageof 15

Showing results (131-140 of 145) with videos related to

Sort By:
Pageof 15
The Journal of Clinical Endocrinology and Metabolism|July 25, 2014
Novel somatic mutations in the catalytic subunit of the protein kinase A as a cause of adrenal Cushing's syndrome: a European multicentric studyGuido Di Dalmazi, Caroline Kisker, Davide Calebiro, et al.
European Urology|November 26, 2013
Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancerAlfredo Berruti, Martin Fassnacht, Harm Haak, et al.
Hypertension (Dallas, Tex. : 1979)|December 29, 2011
KCNJ5 mutations in European families with nonglucocorticoid remediable familial hyperaldosteronismPaolo Mulatero, Philipp Tauber, Maria-Christina Zennaro, et al.
The Journal of Clinical Endocrinology and Metabolism|September 16, 2011
Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumorsWiebke Arlt, Michael Biehl, Angela E Taylor, et al.
Hypertension (Dallas, Tex. : 1979)|May 29, 2014
Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenomaFabio Luiz Fernandes-Rosa, Tracy Ann Williams, Anna Riester, et al.
The New England Journal of Medicine|June 8, 2007
Adjuvant mitotane treatment for adrenocortical carcinomaMassimo Terzolo, Alberto Angeli, Martin Fassnacht, et al.
The Journal of Clinical Endocrinology and Metabolism|November 20, 2012
Mitotane therapy in adrenocortical cancer induces CYP3A4 and inhibits 5α-reductase, explaining the need for personalized glucocorticoid and androgen replacementVasileios Chortis, Angela E Taylor, Petra Schneider, et al.
The Journal of Clinical Endocrinology and Metabolism|January 7, 2015
Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resectionFelix Beuschlein, Jens Weigel, Wolfgang Saeger, et al.
Nature Genetics|February 19, 2013
Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertensionFelix Beuschlein, Sheerazed Boulkroun, Andrea Osswald, et al.
The New England Journal of Medicine|February 28, 2014
Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndromeFelix Beuschlein, Martin Fassnacht, Guillaume Assié, et al.
Pageof 15